28-day mortality in high-risk with severe sepsis receiving eritoran with or without drotrecogin alfa: Analysis of data from a phase II trial

Authors
Publication date
1 January 2010
Publisher
Scholarly Commons @ Baystate Health

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Scholarly Commons @ Baystate Health

    redirect
    oaioai:scholarlycommons.libraryin...
    Last time updated on 30/10/2019